The ActionADE project is part of a larger program of research dedicated to improving medical care for patients at risk for and suffering from adverse drug events (ADEs). Our project team, lead by Drs. Corinne Hohl and Ellen Balka, conducts applied health research to design system interventions to prevent ADEs.

Early roots

When Dr. Corinne Hohl was doing her medical residency, one of her instructors drew her attention to issues of drug safety and polypharmacy, when patients are exposed to multiple prescription drugs.

As Dr. Hohl continued to research and learn about the epidemiology of drug-related adverse events, she started to understand just how common ADEs are – and how often they are ignored. She saw that adverse drug events were not being adequately described in the research literature, and that medical students like herself were not being taught about this kind of potential harm from medications.

Since her early interest in polypharmacy, drug safety and ADEs, Dr. Hohl went on to lead numerous research projects to better understand adverse drug-related events, and identify opportunities to prevent them through health systems-level changes.

Jumping into Action [ADE]

In 2012, Dr. Hohl partnered with Dr. Ellen Balka – a communication and technology expert and professor at SFU – to co-lead ActionADE. The project was awarded Canadian Institutes of Health Research (CIHR) funding for the first several years of the project, and then won continued funding for 2015 – 2019. Initial research included a systematic review, participant design workshops with healthcare providers, and observations of real workplace practices.

Moving forward

We are now working to pilot, refine, implement and evaluate the ActionADE platform in BC, alongside other research projects to better understand the nature of ADEs and how they can be prevented.

For the latest news on our research, please see our publications and presentations.